scispace - formally typeset
K

Keigo Machida

Researcher at University of Southern California

Publications -  92
Citations -  5098

Keigo Machida is an academic researcher from University of Southern California. The author has contributed to research in topics: Homeobox protein NANOG & Hepatitis C virus. The author has an hindex of 37, co-authored 78 publications receiving 4422 citations. Previous affiliations of Keigo Machida include University of Tsukuba & Sapporo Medical University.

Papers
More filters
Journal ArticleDOI

Hepatitis C virus induces a mutator phenotype: Enhanced mutations of immunoglobulin and protooncogenes

TL;DR: It is demonstrated that acute and chronic HCV infection caused a 5- to 10-fold increase in mutation frequency in Ig heavy chain, BCL-6, p53, and β-catenin genes of in vitro HCV-infected B cell lines andHCV-associated peripheral blood mononuclear cells, lymphomas, and HCCs.
Journal ArticleDOI

NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism

TL;DR: It is shown that NANOG is induced by Toll-like receptor 4 (TLR4) signaling via phosphorylation of E2F1 and that downregulation of Nanog slows down hepatocellular carcinoma (HCC) progression induced by alcohol western diet and hepatitis C virus protein in mice.
Journal ArticleDOI

Hepatitis C Virus Triggers Mitochondrial Permeability Transition with Production of Reactive Oxygen Species, Leading to DNA Damage and STAT3 Activation

TL;DR: It is reported that HCV infection causes production of reactive oxygen species (ROS) and lowering of mitochondrial transmembrane potential (ΔΨm) in in vitro HCV-infected cell cultures, and ROS, along with the previously identified NO, are identified as the primary inducers of DSBs and mitochondrial damage in HCV -infected cells.
Journal ArticleDOI

Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog

TL;DR: This study provides the first evidence that Toll-like receptor 4 (TLR4) is induced by hepatocyte-specific transgenic expression of the HCV nonstructural protein NS5A, and this induction mediates synergistic liver damage and tumor formation by alcohol-induced endotoxemia.
Journal ArticleDOI

Hepatitis C Virus Induces Toll-Like Receptor 4 Expression, Leading to Enhanced Production of Beta Interferon and Interleukin-6

TL;DR: Hepatitis C virus infection directly induces TLR4 expression and thereby activates B cells, which may contribute to the host's innate immune responses, and this study analyzes expression and regulation in human B cells following HCV infection in vitro.